Iovance Biotherapeutics (IOVA) Other Operating Expenses (2010 - 2026)
Iovance Biotherapeutics (IOVA) posted Other Operating Expenses of $2.25 million for Q2 2026, up 83.1% from $1.23 million a year earlier but down 15.1% from the prior quarter.
Iovance Biotherapeutics (IOVA) Other Operating Expenses (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Other Operating Expenses at Iovance Biotherapeutics was $105.01 million, up 15.7% year-over-year; for FY2025, it came in at $10.09 million, down 28.9% from FY2024.
- In prior years, Iovance Biotherapeutics' Other Operating Expenses was $14.2 million in FY2024 (-36.8%) and $22.46 million in FY2023.
- Quarterly Other Operating Expenses has run from a low of $1.23 million in Q2 2025 to a high of $52.63 million in Q4 2025 over five years.
- On a year-over-year basis, Other Operating Expenses has increased in each of the last four quarters, with growth averaging 134.4% over the last eight quarters.
- The strongest year-over-year quarter for Other Operating Expenses in the past five years was Q3 2024, with growth of 850.4%; the weakest was Q2 2025, with a decline of 96.1%.
- According to Business Quant data, Other Operating Expenses for the three prior quarters was $2.65 million (Q1 2026), $52.63 million (Q4 2025) and $47.48 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Iovance Biotherapeutics | 3.74 Bn | 2.45 Bn | 73.44 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 4.75 Mn |
| Jun 30, 2026 | 2.25 Mn |
| Mar 31, 2026 | 2.65 Mn |
| Dec 31, 2025 | 5.20 Mn |
| Sep 30, 2025 | 2.34 Mn |
| Jun 30, 2025 | 1.23 Mn |
| Mar 31, 2025 | 1.33 Mn |
| Dec 31, 2024 | 46.94 Mn |
| Sep 30, 2024 | 41.25 Mn |
| Jun 30, 2024 | 31.37 Mn |
| Mar 31, 2024 | 7.26 Mn |
| Dec 31, 2023 | 16.07 Mn |
| Sep 30, 2023 | 4.34 Mn |
| Jun 30, 2023 | 2.05 Mn |
| Mar 31, 2018 | 5.57 Bn |
| Jun 30, 2017 | -37.50 Mn |
| Mar 31, 2017 | 6.50 Bn |
| Jun 30, 2016 | -248.50 Mn |
| Mar 31, 2016 | 7.20 Bn |
| Dec 31, 2014 | 3.06 Mn |
Iovance Biotherapeutics Other Operating Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=IOVA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-operating-expenses", "ticker": "IOVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=IOVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();